Laporan Laba Rugi 1783 - TTM - Maxigen Biotech Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Maxigen Biotech Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	447	458	465	470	494	512	524	557	581	604	624	641	638	622	606	609	624	681	731	766
Change (%)		2.48	1.68	1.01	5.00	3.73	2.39	6.32	4.32	3.95	3.27	2.67	-0.50	-2.44	-2.57	0.51	2.38	9.12	7.36	4.76
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	237	243	236	231	239	251	257	263	248	230	219	210	206	198	191	194	189	197	210	223
Change (%)		2.50	-2.97	-2.27	3.75	4.89	2.60	2.28	-5.74	-7.17	-4.83	-4.07	-1.94	-4.01	-3.55	1.63	-2.70	4.47	6.40	6.11
% of Revenue	53.12	53.13	50.70	49.05	48.47	49.02	49.12	47.25	42.69	38.12	35.14	32.83	32.35	31.83	31.51	31.86	30.28	28.99	28.73	29.10

Gross Operating Profit	209	215	229	239	254	261	267	294	333	374	405	431	431	424	415	415	435	483	521	543
Change (%)		2.45	6.94	4.39	6.20	2.63	2.19	10.23	13.33	12.23	8.26	6.33	0.20	-1.69	-2.11	-0.01	4.76	11.14	7.76	4.22
% of Revenue	46.88	46.87	49.30	50.95	51.53	50.98	50.88	52.75	57.31	61.88	64.86	67.17	67.65	68.17	68.49	68.14	69.72	71.01	71.27	70.90

SG&A	86	84	85	87	89	95	101	115	131	146	164	179	197	206	201	200	190	191	191	182
Change (%)		-2.17	0.48	2.45	2.57	7.22	5.93	13.43	13.92	11.61	12.47	9.21	10.02	4.42	-2.39	-0.15	-5.09	0.63	-0.01	-4.69
% of Revenue	19.29	18.41	18.19	18.45	18.03	18.63	19.28	20.57	22.46	24.11	26.26	27.93	30.89	33.06	33.12	32.90	30.50	28.13	26.20	23.83

R&D	75	69	71	73	67	76	84	92	108	100	88	72	68	69	77	90	96	112	123	125
Change (%)		-8.14	2.32	3.47	-8.37	12.82	11.16	9.47	16.88	-7.43	-11.61	-18.29	-5.82	1.21	11.73	17.11	6.51	17.14	9.65	1.58
% of Revenue	16.85	15.11	15.20	15.57	13.59	14.78	16.05	16.52	18.51	16.48	14.11	11.23	10.63	11.03	12.64	14.73	15.33	16.45	16.80	16.29

OpEx	399	397	391	391	395	422	443	470	486	476	471	461	471	472	468	484	475	501	524	530
Change (%)		-0.52	-1.31	-0.21	1.22	6.76	4.89	6.19	3.48	-2.18	-0.95	-2.11	2.09	0.26	-0.82	3.40	-1.98	5.49	4.68	1.11
% of Revenue	89.26	86.65	84.10	83.08	80.09	82.43	84.44	84.33	83.66	78.72	75.51	71.99	73.86	75.91	77.27	79.49	76.10	73.57	71.73	69.23

Operating Income	48	61	74	80	98	90	82	87	95	129	153	180	167	150	138	125	149	180	207	236
Change (%)		27.37	21.09	7.49	23.57	-8.48	-9.32	7.05	8.82	35.37	18.88	17.43	-7.17	-10.09	-8.06	-9.32	19.31	20.70	14.84	14.04
% of Revenue	10.74	13.35	15.90	16.92	19.91	17.57	15.56	15.67	16.34	21.28	24.49	28.01	26.14	24.09	22.73	20.51	23.90	26.43	28.27	30.77

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	0	0
Change (%)		-47.03	-5.20	-5.91	-5.83	-6.67	-6.12	-13.59	-29.56	-39.29	-61.76	-100.00	NaN
% of Revenue	-0.11	-0.05	-0.05	-0.05	-0.04	-0.04	-0.04	-0.03	-0.02	-0.01	-0.00	0.00	0.00

Net Income	50	63	75	76	94	88	87	99	110	139	163	192	191	166	150	147	155	190	209	208
Change (%)		25.66	18.06	1.15	24.71	-7.02	-1.22	13.97	11.37	26.84	17.15	17.67	-0.38	-13.38	-9.67	-1.75	5.54	22.42	9.82	-0.38
% of Revenue	11.28	13.83	16.06	16.08	19.10	17.12	16.52	17.71	18.90	23.06	26.16	29.98	30.02	26.66	24.71	24.16	24.90	27.94	28.58	27.18

Source: Capital IQ

Maxigen Biotech Inc. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)